Spend the most, live the shortest
Among large, wealthy nations, the United States spends more on health care than any of them — and by a wide margin. In 2024 it spent nearly $5,000 more per person than the next-highest-spending country, Switzerland, and roughly $7,000 more than the average of its peers. No country is close.
And yet, on the single broadest measure of whether a health system is working — how long people live — the United States ranks at or near the bottom of that same group. Its life expectancy sits roughly 3.7 years below the comparable-country average. The country that spends the most lives the shortest among its peers. On other basic measures — infant mortality, safety in childbirth, unmanaged chronic disease — the pattern repeats.
The natural assumption is that Americans must simply use far more care. They do not. For many services, US utilization is at or below peer-country levels — shorter hospital stays, fewer of some procedures. What differs is the price of each unit of care. The US pays more for the same office visit, the same scan, the same drug. It is fundamentally a price story, not a story of a population consuming too much medicine. This echoes the finding from earlier in this section: the problem is not that people get too much care. At the level that prevents expensive disease, many get too little.
What it costs to actually receive care
The two-times figure is accurate, but it needs to be read for what it is. It divides total national health spending by total population. It is a measure of what the system costs. It says nothing about what it costs you to walk through a door when something is wrong — and that second number is the one that decides whether you go.
The natural assumption is that peer nations have simply abolished the cost of seeking care. They have not, and it is worth being precise about this. Of the twenty-eight OECD countries with universal coverage, the large majority expect patients to share some cost — copayments, coinsurance, and in a few cases deductibles. Cost-sharing is not an American invention.
The cap is.
Nearly every peer system places a hard ceiling on what a person can be made to pay, and sets that ceiling at a level a household can absorb:
In the United Kingdom and Canada, physician and hospital care is free at the point of use outright. In the United States, a person faces a deductible first — averaging $1,886 for single coverage — then coinsurance, up to a federal out-of-pocket maximum that runs around $9,200 for an individual and $18,400 for a family.
Set those side by side for a person earning $60,000 a year. In Germany, the most that person can be required to pay for health care in a year is roughly $1,200. Not the most they will likely pay — the most they can be made to pay. In the United States, the same person faces up to $9,200, or about fifteen percent of their gross income, before coverage takes over.
And the American ceiling is not a ceiling
That $9,200 has a condition attached that changes everything: it only applies in network.
Step outside the network and the cap evaporates. Travel to another state and need care. Have an emergency and get taken to the nearest hospital rather than the correct one. Be treated at an in-network facility by an out-of-network anesthesiologist you never chose and never met. In each case the protection simply does not apply, and the exposure has no defined limit.
The concept of a "network" — of being financially devastated because you sought care in the wrong building — is very nearly an American original. In most peer systems there is no network in this sense. You are covered because you are a person, not because you picked the right hospital.
The system-level comparison says the United States spends about twice as much per person. The person-level comparison says something categorically different: elsewhere, the cost of getting care is small and certain. Here, it is large and unpredictable — and the worst case is effectively unbounded.
That distinction is the whole reason roughly 41% of American adults carry medical debt, a burden that is virtually nonexistent in Germany. And it is why the two-times figure, accurate as it is, understates what Americans actually experience. You do not defer care because national health expenditure is high. You defer it because you cannot predict what walking through the door will cost you.
The fact that changes everything: 1980
Here is the single most important number in this primer, and perhaps in the whole section. In 1980, the United States looked like its peers. It spent about what they spent on health care, and its people lived about as long. The two lines — American spending and life expectancy against everyone else's — sat together.
Then they diverged. Over the following four decades, US spending climbed far above every peer nation while its life-expectancy gains fell behind. The gap that now looks like a permanent feature of the American landscape is not permanent at all. It opened within living memory, and it opened as the result of choices — about how care would be organized, financed, and delivered.
Not all of the outcome gap is the health system's fault. The US carries heavier burdens from some factors that sit outside medicine — obesity and diet, gun violence, traffic fatalities, drug overdoses — and these pull life expectancy down independently of how good the hospitals are. The US also genuinely excels at some things: advanced specialty care, cancer survival for certain diagnoses, cutting-edge intervention. The gap is real, but it is honest to say it is a gap in population health and delivery reach, not in the peak capability of American medicine.
The framework's reading
Every other wealthy nation achieves what the United States does not: universal or near-universal coverage, at roughly half the per-person cost, with longer lives on average. They do not do this because their doctors are better or their science is more advanced — in many cases American medicine leads the world at the frontier. They do it because they organize delivery differently. The care reaches people, continuously, without the intermediary layers and access barriers documented throughout this section.
That is the whole case this framework makes, reflected back from the rest of the world. The deficit was never knowledge, and clearly never money — the US spends more than anyone. It is delivery: the organized capacity to bring good primary care to real people, before crisis, without the friction that turns manageable problems into expensive ones. The 1980 divergence is the proof that this is not destiny. A system that once matched its peers can match them again — not by spending more, which it already does, but by delivering better. Alma-Ata named the design in 1978: care made universally accessible, at a cost the community can afford. The international mirror shows what following that design, or failing to, actually produces over forty years.
Which leaves the section standing in front of a question it has spent seven primers earning the right to ask.
The costs are known. They are published every year and disputed by no one. A better outcome is not theoretical — every peer nation achieves it, and the United States itself achieved it within living memory. The design was written down in 1978.
So why don't we?
That is the last question, and the hardest, and it is not answered by any number in the landscape. People have tried. Vermont tried. Colorado tried. California has tried six times. Britain tried, succeeded in covering everyone, and is still struggling with what came after. What happened to them is the next part of this section — and what happened to them is the same thing, every time.